日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TROP2/claudin program mediates immune exclusion to impede checkpoint blockade in breast cancer.

TROP2/claudin 程序介导免疫排斥,从而阻碍乳腺癌中的检查点阻断。

Wu Bogang, Thant Win, Bitman Elena, Liu Ting, Liu Jie, Paschalis Eleftherios I, Patel Bidish K, Nawrocki Cole, Xu Katherine H, Nieman Linda T, Ting David T, de Gois Macedo Bruna, Cheng Yang, Jiang Kevin, Sun Fengfei, Thimmiah Nayana, Sun Sheng, Abelman Rachel O, Bossuyt Veerle I, Isakoff Steven J, Spring Laura M, Bardia Aditya, Ellisen Leif W

TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer.

转移性乳腺癌患者中TOP1突变和抗体药物偶联物的交叉耐药性

Abelman Rachel O, Wu Bogang, Barnes Haley, Medford Arielle, Norden Bryanna, Putur Annika, Bitman Elena, Thant Win, Liu Ting, Weipert Caroline, Fell Geoffrey, Spring Laura M, Wander Seth A, Moy Beverly, Vidula Neelima, Isakoff Steven J, Varkaris Andreas, Juric Dejan, Corcoran Ryan B, Ellisen Leif W, Bardia Aditya

Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER)

使用细胞周期蛋白依赖性激酶 4/6 抑制剂 ribociclib 进行辅助内分泌治疗,用于治疗局部激素受体阳性/HER2- 乳腺癌(LEADER)

Spring, Laura M; Scarpetti, Lauren; Medford, Arielle J; Niemierko, Andrzej; Comander, Amy; Mulvey, Therese; Schnipper, Lowell; Isakoff, Steven J; Moy, Beverly; Wander, Seth A; Shin, Jennifer; Ephrem, Zanta; Laposta, Anneke R; Denault, Elyssa; Abraham, Elizabeth; Calistro, Gayle; Kalashnikova, Ekaterina; Rodriguez, Angel; Liu, Minetta C; Aleshin, Alexey; Peppercorn, Jeffrey; Ellisen, Leif W; Bardia, Aditya

Dynamic HER2-low status among patients with triple negative breast cancer (TNBC) and the impact of repeat biopsies

三阴性乳腺癌(TNBC)患者中HER2低表达状态的动态变化及其对重复活检的影响

Bar, Yael; Fell, Geoffrey; Dedeoglu, Aylin; Moffett, Natalie; Vidula, Neelima; Spring, Laura; Wander, Seth A; Bardia, Aditya; Ko, Naomi; Moy, Beverly; Ellisen, Leif W; Isakoff, Steven J

Selection biases in the systematic collection of breast biobank specimens

系统性收集乳腺生物样本库标本中的选择偏差

Bar, Yael; Wang, Gary X; Gioia, Gabrielle E; Fell, Geoffrey; Chou, Shinn-Huey S; Bossuyt, Veerle; Isakoff, Steven J; Moy, Beverly; Ellisen, Leif W; Lehman, Constance D; Spring, Laura M

Current landscape of sequencing ADCs in metastatic breast cancer

转移性乳腺癌中抗体药物偶联物(ADC)测序的现状

McLaughlin, Shannon; Ravani, Lis V; Moy, Beverly; Medford, Arielle J; Isakoff, Steven J; Liu, Ting; Ellisen, Leif W; Spring, Laura M; Wander, Seth A; Abelman, Rachel O

Leveraging real-world evidence to personalize adjuvant therapy in HR+/HER2- early breast cancer

利用真实世界证据为HR+/HER2-早期乳腺癌患者制定个体化的辅助治疗方案

Bar, Yael; Isakoff, Steven J; Wander, Seth A

Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT

辅助曲妥珠单抗-美坦新与紫杉醇联合曲妥珠单抗治疗I期人表皮生长因子受体2阳性乳腺癌:ATEMPT研究的5年结果及相关性分析

Tarantino, Paolo; Tayob, Nabihah; Villacampa, Guillermo; Dang, Chau; Yardley, Denise A; Isakoff, Steven J; Valero, Vicente; Faggen, Meredith; Mulvey, Therese; Bose, Ron; Weckstein, Douglas; Wolff, Antonio C; Reeder-Hayes, Katherine; Rugo, Hope S; Ramaswamy, Bhuvaneswari; Zuckerman, Dan; Hart, Lowell; Gadi, Vijayakrishna K; Constantine, Michael; Cheng, Kit; Garrett, Audrey Merrill; Marcom, P Kelly; Albain, Kathy; DeFusco, Patricia; Tung, Nadine; Ardman, Blair; Nanda, Rita; Jankowitz, Rachel C; Rimawi, Mothaffar; Abramson, Vandana; Pohlmann, Paula R; Van Poznak, Catherine; Forero-Torres, Andres; Liu, Minetta C; Ruddy, Kathryn J; Waks, Adrienne G; DeMeo, Michelle; Burstein, Harold J; Partridge, Ann H; Dell'Orto, Patrizia; Russo, Leila; Krause, Emma; Newhouse, Daniel J; Kurt, Busem Binboğa; Mittendorf, Elizabeth A; Schneider, Bryan; Prat, Aleix; Winer, Eric P; Krop, Ian E; Tolaney, Sara M

First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results

一线伊帕他替尼、阿特珠单抗和紫杉烷三联疗法治疗转移性三阴性乳腺癌:临床和生物标志物结果

Schmid, Peter; Turner, Nicholas C; Barrios, Carlos H; Isakoff, Steven J; Kim, Sung-Bae; Sablin, Marie-Paule; Saji, Shigehira; Savas, Peter; Vidal, Gregory A; Oliveira, Mafalda; O'Shaughnessy, Joyce; Italiano, Antoine; Espinosa, Enrique; Boni, Valentina; White, Shane; Rojas, Beatriz; Freitas-Junior, Ruffo; Chae, Yeesoo; Bondarenko, Igor; Lee, Jieun; Torres Mattos, Cesar; Martinez Rodriguez, Jorge Luis; Lam, Lisa H; Jones, Surai; Reilly, Sarah-Jayne; Huang, Xiayu; Shah, Kalpit; Dent, Rebecca

Ipatasertib plus Paclitaxel for Patients with PIK3CA/AKT1/PTEN-Altered Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer in the IPATunity130 Phase III Trial

IPATunity130 III期试验中,Ipatasertib联合紫杉醇治疗PIK3CA/AKT1/PTEN改变的局部晚期不可切除或转移性三阴性乳腺癌患者

Dent, Rebecca A; Kim, Sung-Bae; Oliveira, Mafalda; Barrios, Carlos; O'Shaughnessy, Joyce; Isakoff, Steven J; Saji, Shigehira; Freitas-Junior, Ruffo; Philco, Manuel; Bondarenko, Igor; Lian, Qinshu; Bradley, Denise; Hinton, Heather; Wongchenko, Matthew J; Reilly, Sarah-Jayne; Turner, Nicholas